MedTrace Logo

HIV Prevention Preparedness Study

NCT00048282 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2010-05-14

No results posted yet for this study

Summary

The purpose of this study is to provide researchers with information that will help them prepare for a future study to test the efficacy of two anti-HIV vaginal gels. This study will also estimate how likely people living in certain areas are to become infected with HIV and other infections passed during sex.

Conditions

  • HIV Infections
  • HIV Seronegativity

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Saidi Kapiga, MD, MPH, SCD · Harvard School of Public Health (HSPH)

  • Gita Ramjee, PhD · South Africa Medical Research Council

  • Stephen Weiss, PhD · University of Miami

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Countries

  • South Africa
  • Tanzania
  • Zambia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00048282 on ClinicalTrials.gov